The prognostic value of derived neutrophil to lymphocyte ratio in oesophageal cancer treated with definitive chemoradiotherapy

Cox, Samantha; Hurt, Chris; Grenader, Tal; Mukherjee, Somnath; Bridgewater, John; Crosby, T.

doi:10.1016/j.radonc.2017.08.023

Public

The prognostic value of derived neutrophil to lymphocyte ratio in oesophageal cancer treated with definitive chemoradiotherapy

Published in Radiotherapy and Oncology • Sep 8, 2017

Authors:

Samantha Cox

Chris Hurt

Tal Grenader

Abstract

BACKGROUND AND PURPOSE: The derived neutrophil-lymphocyte ratio (dNLR) is a validated prognostic biomarker for cancer survival but has not been extensively studied in locally-advanced oesophageal cancer treated with definitive chemoradiotherapy (dCRT). We aimed to identify the prognostic value of dN...

Subject

Medicine

Internal medicine

Chemoradiotherapy

Research Assistant

AI chat, annotations, notes & similar papers

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!